Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2982772 in Active Ulcerative Colitis
NCT02903966Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2016
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial in ulcerative colitis (UC) comparing GSK2982772 Arm with Placebo Arm (2 arms). Primary endpoints: Number of Participants With Common (>=5%) Non-serious Adverse Events and Any Serious Adverse Events at Day 112, Number of Participants With Worst Case Abnormal Clinical Chemistry Parameters at Day 112 and 5 more. Started Nov 2016; status: completed.
02
Drugs
GSK2982772
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02903966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903966.